Keio University Hospital has completed the scheduled follow-up observations and data collection for all four cases in its clinical study on regenerative medicine using iPS cell-derived neural stem/progenitor cells to treat subacute spinal cord injuries.
Moving forward, we will promptly submit a comprehensive report and summary to the Minister of Health, Labour and Welfare in accordance with the Act on Securing Safety of Regenerative Medicine and related regulations.
